Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAESTRO-NASH: Resmetirom in NASH and Fibrosis
NCT03900429Phase 3Active, not recruiting
- Sponsor
- Madrigal Pharmaceuticals
- Start
- Mar 2019
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 3 trial of resmetirom in Nonalcoholic steatohepatitis (NASH), sponsored by Madrigal Pharmaceuticals. Started Mar 2019; status: active, not recruiting.
02
Drugs
resmetirom
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT03900429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03900429.